KEAP1 and non-small cell lung carcinoma: KEAP1-mutant non-small-cell lung cancer (NSCLC) induces Nrf2 to activate the expression of thioredoxins and peroxiredoxins, which are critical for Nrf2-dependent growth and proliferation in KEAP1-mutant cell lines (47).